Leadership Overview
WuXi AppTec has 7 executives leading key functions including strategy, technology, finance, and operations.
Driven by innovation, WuXi AppTec provides comprehensive research and manufacturing services for drug discovery and development, impacting global health through advanced therapies and small molecule drugs.
Driven by innovation, WuXi AppTec provides comprehensive research and manufacturing services for drug discovery and development, impacting global health through advanced therapies and small molecule drugs.
Leadership Roles at WuXi AppTec
Ge Li - Chief Executive Officer
Ge Li, the Chief Executive Officer at WuXi AppTec, directs the company's overarching strategy and operational execution. This leadership role involves guiding WuXi AppTec's mission to provide a broad and integrated portfolio of R&D and manufacturing services, enabling companies worldwide to discover, develop, and manufacture therapeutics. Li oversees the company's global operations, ensuring seamless integration across its WuXi Chemistry, WuXi Testing, WuXi Biology, and WuXi ATU segments. The Chief Executive Officer's focus remains on driving innovation and efficiency within the contract research, development, and manufacturing organization (CRDMO) space. By fostering a culture of scientific excellence and client collaboration, Ge Li ensures WuXi AppTec remains at the forefront of advancing new drug development from discovery through commercialization, supporting the creation of small molecule drugs and advanced therapies across China, the United States, and Europe.

Minzhang Chen - Co-Chief Executive Officer
Minzhang Chen, the Co-Chief Executive Officer at WuXi AppTec, shares executive leadership responsibilities, focusing on strategic growth and operational excellence. Chen's role involves driving the expansion of WuXi AppTec's service offerings and market reach, particularly within the complex landscape of drug discovery and manufacturing. This leadership position requires close collaboration with other senior executives to ensure the company's integrated platform effectively serves clients in the People's Republic of China, the United States, and Europe. Minzhang Chen oversees key initiatives aimed at enhancing the company's capabilities in areas such as synthetic molecular modalities, including small molecules, oligonucleotides, and peptides. The Co-Chief Executive Officer's strategic vision supports the development of advanced therapies and ensures WuXi AppTec's continued leadership in the global CRDMO sector, facilitating the journey from initial research to market-ready products.

Steve Yang - Co-Chief Executive Officer
Steve Yang, the Co-Chief Executive Officer at WuXi AppTec, contributes to the company's strategic direction and global operational management. Yang's responsibilities encompass driving the company's growth initiatives and ensuring the efficient delivery of its comprehensive R&D and manufacturing services. This executive position involves fostering strong client relationships and overseeing the integration of WuXi AppTec's diverse business segments, including WuXi Chemistry, WuXi Testing, and WuXi Biology. The Co-Chief Executive Officer plays a critical part in navigating the international pharmaceutical and biotechnology markets, supporting clients in the discovery, development, and manufacturing of innovative therapeutics. Steve Yang's leadership ensures WuXi AppTec maintains its competitive edge by providing cutting-edge solutions for small molecule drugs and advanced therapies across its global operational footprint.
Florence Shi - Senior Vice President, Chief Financial Officer
Florence Shi, the Senior Vice President, Chief Financial Officer at WuXi AppTec, directs the company's financial strategy and fiscal management. Shi's responsibilities encompass overseeing all financial operations, including accounting, financial planning, treasury, and investor relations, ensuring robust financial health and compliance across global operations. This executive role is critical in supporting WuXi AppTec's strategic growth initiatives and capital allocation for research, development, and manufacturing expansion. The Chief Financial Officer plays a key part in managing the financial aspects of the company's diverse segments, from WuXi Chemistry to WuXi ATU, and in communicating financial performance to stakeholders. Florence Shi's leadership ensures financial stability and supports the company's mission to enable clients worldwide in bringing innovative therapeutics to market.

Daisy Liu - President
Daisy Liu, the President at WuXi AppTec, holds a significant leadership position overseeing key operational aspects and strategic initiatives across the organization. Liu's role involves driving the execution of the company's business objectives and ensuring the seamless delivery of its comprehensive R&D and manufacturing services. This executive function requires close collaboration with the Co-Chief Executive Officers and other senior leaders to optimize performance across WuXi AppTec's various segments, including WuXi Chemistry, WuXi Testing, and WuXi Biology. The President's focus is on enhancing operational efficiency and client satisfaction, supporting the development of small molecule drugs and advanced therapies. Daisy Liu's leadership contributes to WuXi AppTec's global strategy, reinforcing its commitment to enabling pharmaceutical and biotechnology companies worldwide.
David Chang - Chief Technology Officer
David Chang, the Chief Technology Officer at WuXi AppTec, spearheads the company's technological innovation and infrastructure development. Chang's role is pivotal in advancing the capabilities across WuXi AppTec's research and manufacturing services, ensuring the integration of cutting-edge technologies in drug discovery and development. This leadership position involves overseeing the technological roadmap for all segments, including WuXi Chemistry, WuXi Testing, and WuXi Biology, to support the creation of small molecule drugs and advanced therapies. The Chief Technology Officer drives the adoption of new platforms and methodologies that enhance efficiency, scalability, and scientific rigor. David Chang's expertise ensures WuXi AppTec provides state-of-the-art solutions to its global clientele, reinforcing the company's position as a leading CRDMO by leveraging technology to accelerate therapeutic breakthroughs.

Xiaozhong Liu - Executive VP & Head of the Strategic Project Office
Xiaozhong Liu, the Executive VP & Head of the Strategic Project Office at WuXi AppTec, directs critical strategic projects and ensures their successful implementation across the organization. Liu's leadership is focused on managing complex, high-impact initiatives that align with WuXi AppTec's long-term vision and growth objectives. This executive role involves overseeing project lifecycles, resource allocation, and risk management to ensure timely and effective delivery of strategic goals. The Head of the Strategic Project Office works closely with various departments, including WuXi Chemistry, WuXi Testing, and WuXi Biology, to integrate new capabilities and optimize existing operations. Xiaozhong Liu's strategic oversight is instrumental in advancing WuXi AppTec's capabilities in drug discovery, development, and manufacturing, supporting the company's mission to serve clients globally.
Explore Leadership Teams in Business Services
Barrios Technology is a woman-owned aerospace business that has been providing high-quality engineering, software, and technology integration solutions for over 45 years. They serve both government and commercial space flight programs, including significant contributions to NASA's human spaceflight initiatives. Their services encompass space mission integration, software engineering, systems engineering, and data analytics solutions. Barrios is committed to innovation and advancing humanity, both on and off the planet, while also supporting local communities through STEM-focused initiatives.
Company Leadership LG
JC
The Stowers Institute for Medical Research is dedicated to uncovering the fundamental biological processes that lead to innovative approaches for diagnosing, treating, and preventing diseases. With a focus on foundational research, the institute collaborates with experts in its Technology Centers to drive transformative scientific discoveries. It also emphasizes education and outreach, supporting motivated individuals through its accredited Graduate School and various training programs. The institute's unique funding model, established by its founders, allows scientists the freedom to explore and share their findings for the betterment of humanity.
Company Leadership

AA
MG
Lynker specializes in environmental consulting, scientific and technical services, and enterprise IT. Our continually expanding team operates in 18 states and stretches across every time zone in the Continental US and Pacific Islands. We combine scientific and engineering expertise with mature, results-driven processes and tools to achieve technically sound, cost effective solutions in geospatial, marine ocean, and coastal science and information, water and environmental resources, and integrated technology services. Lynker is a certified HUBZone business with offices in Leesburg VA, Boulder CO, and Oahu HI.
Company Leadership JL

TW
MS
Located in Burbank California, Micro Quality Labs specializes in providing Microbiological and Analytical testing services for the Cosmetic, Pharmaceutical, Nutritional and Food industries. The company's mission is to provide excellent customer service in addition to being efficient and reliable. The company is hands on and work closely with the company's clients to assure the company's mutual success. Micro Quality Labs was established in 2003 and is registered with the FDA, EPA and Health Canada. The company strictly adhere to cGMP standards and the company's equipment and instrumentation is state of the art. I am proud to announce that after more than a year of hard work, intense training and on-going audits, the company recently attained the company's ISO 17025 certification. ISO 17025 is an internationally recognized standard to measure laboratories on quality, management and technical requirements, and to recognize excellence in operations. This accreditation spotlights Micro Quality Labs commitment to delivering services of the best quality to its customers based on the highest internationally recognized practices and procedures. The company understands that trust is not given it is earned; At Micro Quality Labs, the company works hard everyday to earn your trust. The company knows that is not only the company's technical know-how that makes the company stand out but the company's people. The company has a great team that is highly trained and dedicated to working together to achieve the company's common goals. Please call the company today and experience the difference of the exceptional service of the team at Micro Quality Labs.
Company Leadership

JS
MR